1. Home
  2. VNO vs AMRX Comparison

VNO vs AMRX Comparison

Compare VNO & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vornado Realty Trust

VNO

Vornado Realty Trust

SELL

Current Price

$32.87

Market Cap

6.3B

Sector

Real Estate

ML Signal

SELL

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

SELL

Current Price

$19.25

Market Cap

6.4B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
VNO
AMRX
Founded
1946
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
6.4B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
VNO
AMRX
Price
$32.87
$19.25
Analyst Decision
Hold
Strong Buy
Analyst Count
13
7
Target Price
★ $39.38
$22.71
AVG Volume (30 Days)
1.3M
★ 2.9M
Earning Date
11-02-2026
11-03-2026
Dividend Yield
★ 2.23%
N/A
EPS Growth
★ 10400.00
157.89
EPS
N/A
★ 0.37
Revenue
★ $1,810,425,000.00
N/A
Revenue This Year
$0.86
$4.53
Revenue Next Year
$6.92
$9.13
P/E Ratio
★ N/A
$52.01
Revenue Growth
★ 1.27
N/A
52 Week Low
$24.57
$9.92
52 Week High
$41.60
$21.18

Technical Indicators

Market Signals
Indicator
VNO
AMRX
Relative Strength Index (RSI) 37.51 47.30
Support Level $28.48 $16.59
Resistance Level $34.83 $19.26
Average True Range (ATR) 0.90 0.62
MACD 0.04 -0.19
Stochastic Oscillator 30.40 11.78

Price Performance

Historical Comparison
VNO
AMRX

About VNO Vornado Realty Trust

Vornado Realty Trust is a fully integrated real estate investment trust with a portfolio of New York City office, retail, and multifamily assets, and the developer of the new Penn District. While concentrated in New York, the trust also owns assets in both Chicago and San Francisco. It generates revenue in the form of property rentals, fees charged for trade shows, parking revenues, management and leasing fees, etc. Vornado operates in the following reportable segments: New York (its key revenue-generating market) and Other.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: